Stage III Prostate Cancer AJCC v8 Clinical Trials

54 clinical trials for Stage III Prostate Cancer AJCC v8 across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy — RECRUITING · NA
• Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer — RECRUITING · NA
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma — RECRUITING · NA
• SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma — RECRUITING · PHASE3
• Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer — RECRUITING · PHASE3
• Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer — RECRUITING · PHASE2
• Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors — RECRUITING · NA
• Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance — RECRUITING · PHASE4
• Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation — RECRUITING · NA
• Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer — RECRUITING · NA
• Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer — RECRUITING · PHASE2
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial — RECRUITING · PHASE2
• Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer — RECRUITING · PHASE2
• REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial — RECRUITING · PHASE3
• Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer — RECRUITING · NA
• Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial — RECRUITING · NA
• Vitamin D for Prostate Endocrine Therapy — RECRUITING · PHASE3
• Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial — RECRUITING · NA
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy — RECRUITING · PHASE2
• Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations — ACTIVE_NOT_RECRUITING · PHASE2
• Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners — ACTIVE_NOT_RECRUITING · NA
• Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring — COMPLETED · PHASE1
• Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer — SUSPENDED · NA
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV — ACTIVE_NOT_RECRUITING · PHASE1
• Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy — COMPLETED · PHASE2
• Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE1
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer — TERMINATED · PHASE2
• Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans — ACTIVE_NOT_RECRUITING · NA
• RElugolix VErsus LeUprolide Cardiac Trial — ACTIVE_NOT_RECRUITING · PHASE2
• Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study — COMPLETED
• Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners — ACTIVE_NOT_RECRUITING
• An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial — COMPLETED · NA
• Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes — COMPLETED
• Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer — WITHDRAWN · PHASE2
• LiSWT for Nerve Sparing Radical Prostatectomy ED — COMPLETED · NA
• EXERCISING TOGETHER for Couples Coping With Cancer — COMPLETED · NA
• Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer — WITHDRAWN · PHASE2
• Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer — WITHDRAWN · PHASE1
• An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer — COMPLETED · NA
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer — COMPLETED · PHASE1
• Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer — COMPLETED · PHASE1
• Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy — TERMINATED
• A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1

Refine this search